Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions.

已完结 10 由 wzy123 发布于 2025/7/6 16:40:39

DOI:10.1080/14737140.2024.2414071
作者：Aram Bidikian,?Jan P Bewersdorf,?Rory M Shallis,?Ted M Getz,?Jessica M Stempel,?Tariq Kewan,?Maximilian Stahl,?Amer M Zeidan
文献类型：期刊论文
补充材料：只需要正文

Taylor & Francis

Abstract：Introduction: Myelodysplastic syndromes/neoplasms (MDS) are a heterogeneous group of hematologic malignancies that are stratified into high-risk (HR-MDS) and low-risk (LR-MDS) categories. Un

应助信息

13小时前

yiqiang

131d675b5a4611f0a13934735aa3bc31.pdf 已采纳

13小时前

Book学术机器人

2025/7/6 16:40:39 未找到该文献，机器人已退出，请等待人工下载

2025/7/6 16:40:39 Book学术AI机器人收到请求，开始寻找文献

2025/7/6 16:40:39 已向机器人发送请求

13小时前

wzy123 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureAI-generated literature reviews threaten scientific progress